Dr. Christopher G Morais Jr. is a Miami, Florida based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Christopher G Morais Jr. is 36500 in Florida. Dr. Christopher G Morais Jr. is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Christopher G Morais Jr. speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
900 Nw 17th St, Miami, Florida, 33136-1134
Phone:
305-326-6021
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1851015762
NPI Enumeration Date:
04 Oct, 2022
NPI Last Update On:
04 Oct, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Christopher G Morais Jr. are as mentioned below.
License Number
Specialization
State
Status
36500
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
908 Stanton Dr, Weston, Florida
Zip:
33326-3595
Phone Number:
303-956-6277
Fax Number:
--
Patients can reach Dr. Christopher G Morais Jr. at 900 Nw 17th St, Miami, Florida or can call to book an appointment on 305-326-6021. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.